BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6488011)

  • 1. Hypothalamic knife cuts attenuate maintenance of deoxycorticosterone acetate-salt induced hypertension.
    Bealer SL
    Brain Res; 1984 Aug; 309(1):192-5. PubMed ID: 6488011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH; Barron KW; Webb RL; Brody MJ
    Hypertension; 1982; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of transection in the brainstem on short-term maintenance of deoxycorticosterone-salt hypertension.
    Cannata MA; Musi EA; Gomez RE
    Brain Res; 1987 Sep; 420(2):295-301. PubMed ID: 3676762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of AV3V lesions on development of DOCA-salt hypertension and vascular Na+-pump activity.
    Songu-Mize E; Bealer SL; Caldwell RW
    Hypertension; 1982; 4(5):575-80. PubMed ID: 6286476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased density of glutamic acid decarboxylase-containing terminals in the medial preoptic nucleus and the area surrounding the paraventricular hypothalamic nucleus is associated with deoxycorticosterone acetate (DOCA)-salt hypertension.
    Zappia A; Hwang BH; Wu JY
    Anat Rec; 1990 Aug; 227(4):518-22. PubMed ID: 2393103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of forebrain mechanisms in the maintenance of deoxycorticosterone acetate-salt hypertension.
    Ciriello J
    Clin Exp Hypertens A; 1988; 10 Suppl 1():169-78. PubMed ID: 3242987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCA-salt rats.
    Fujita T; Sato Y; Ando K
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H926-33. PubMed ID: 2877584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of salt and DOCA on hypothalamic and baroreflex control of blood pressure.
    Takeda K; Nakamura Y; Hayashi J; Kawasaki S; Nakata T; Oguro M; Sasaki S; Nakagawa M
    Clin Exp Hypertens A; 1988; 10 Suppl 1():289-99. PubMed ID: 3242995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lesions of the anteroventral third ventricle (AV3V) on the development of hypertension in spontaneously hypertensive rats.
    Gordon FJ; Haywood JR; Brody MJ; Johnson AK
    Hypertension; 1982; 4(3):387-93. PubMed ID: 7068195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hypothalamic lesions on interaction of centrally administered ANF and the circulating sodium-pump inhibitor.
    Songu-Mize E; Bealer SL
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S4-6. PubMed ID: 7508025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCl inhibits hypothalamic activity to attenuate hypertension in DOCA-salt rats.
    Sasaki S; Takeda K; Takahashi H; Yoneda S; Okajima H; Iyoda I; Yoshimura M; Ijichi H
    Jpn Circ J; 1984 Nov; 48(11):1251-9. PubMed ID: 6502916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamus and sodium-potassium pump activity in skeletal muscles of DOCA-hypertensive rats.
    Katafuchi T; Oomura Y; Maruyama T; Akaike N
    Am J Physiol; 1987 Sep; 253(3 Pt 2):R396-401. PubMed ID: 2820248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periventricular forebrain mechanisms for blood pressure regulation.
    Buggy J; Huot S; Pamnani M; Haddy F
    Fed Proc; 1984 Jan; 43(1):25-31. PubMed ID: 6360715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DOCA-salt treatment duration and anteroventral third ventricle lesions on a plasma-borne sodium pump inhibitor in rats.
    Songu-Mize E; Bealer SL; Caldwell RW
    J Hypertens; 1987 Aug; 5(4):461-7. PubMed ID: 3668248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphagia and obesity produced by parasagittal and coronal hypothalamic knife cuts: further evidence for a longitudinal feeding inhibitory pathway.
    Sclafani A; Berner CN
    J Comp Physiol Psychol; 1977 Oct; 91(5):1000-18. PubMed ID: 925205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOCA/salt hypertension alters Period1 and orexin-related gene expression in the medulla and hypothalamus of male rats: Diurnal influences.
    Hernandez ME; Watkins JM; Vu J; Hayward LF
    Auton Neurosci; 2018 Mar; 210():34-43. PubMed ID: 29246398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.